US Energy Initiatives Corp (USEI)

[IPdaily]

ON Monday, July 28, 2014 introduced the "Charlotte's Web Medical Hemp Act of 2014 (H.R.)" to Congress.

The bill proposes to exclude industrial hemp and cannabidiol (CBD) from the definition of marijuana, ensuring that children and individuals with epilepsy and other debilitating seizure disorders have access to life-changing Cannabidiol (CBD) Oil and therapeutic hemp such as the Charlotte's Web™ brand of hemp products. High CBD hemp strains have provided relief for thousands of people in the United States as it's shown to reduce the amount and duration of seizures in children suffering from epilepsy and other seizure disorders.

Through cross breeding hemp varieties and landrace strains of cannabis, the Stanley brothers of Colorado developed a rare new strain of hemp that is marketed under the Charlotte's Web™ brand. Charlotte's Web™ products help create a better quality of life for patients of all ages affected by diseases such as cancer, multiple sclerosis, HIV/AIDS, Parkinson's and other debilitating conditions.

Charlotte's Web™ yields the highest known recorded levels of CBD, with very low levels of tetrahydrocannabinol (THC), the psychoactive compound in cannabis. Charlotte's Web™ offers the beneficial and therapeutic properties of medical marijuana without the psychoactive side effects accompanied by THC. Research suggests that CBD - the compound in cannabis that's demonstrated neuroprotective effects - has significant anti-inflammatory and anti-tumoral properties.

http://www.theroc.us/index.php?option=com_k2&view=item&id=22:charlotte-s-web-medical-hemp-act-of-2014&Itemid=498